MYSM1 and cardiac hypertrophy: The levels of vacuolar changes in the vacuole, inflammatory infiltration infiltrations and glomerular scleroses in the kidney, cardiac hypertrophy in the heart, and inflammatory infiltrations and vacuolations in the liver were clearly reduced by AAV9‐Mysm1 (Figure 6K–M).